Pharmaceutical Executive February 9, 2024
According to the study conducted by Technavio, North America will contribute to 37% of the expected growth.
The generic drug market is expected to show significant growth in the coming years.
At least, that’s according to a new study conducted by Technavio, a leading global technology research and advisory company.1 In a press release, the research company detailed the estimated growth, stating that it believes the market will grow by $176.25 billion by 2027. It also states that North America will contribute about 37% of this growth.
In the press release, a senior analyst at Technavio said, “The rising drug patent expirations are notably driving the generic drug market growth. Patent...
Today's Sponsors
Today's Sponsor